https://www.avient.com/sites/default/files/2022-01/Dynaflex-Disposable syringe tip cap-Application snapshot.pdf
Formulated a solution that met rigorous
medical application requirements
• Leveraged global footprint to ensure supply
continuity
• Increased process efficiency by replacing
previous thermoset material with TPE
LEARN MORE
https://www.avient.com/products/thermoplastic-elastomers/dynaflex-thermoplastic-elastomers
https://www.avient.com/sites/default/files/2023-10/ISO 13485-2016 cert_expire 28Feb2025_Avient%5B28%5D.pdf
2
/Ju
n-
20
19
/V
er
si
on
1
.0
Certificate
Avient Colorants Singapore Pte Ltd
8 Third Chin Bee Road
Jurong Industrial Estate
618684 Singapore
Singapore
Scope
Administration, Site management, Manufacture,
Laboratory, Procurement, Maintenance,
infrastructure, Warehouse and Transport
Normative base
EN ISO 13485:2016 Medical devices – Quality Management System
Reg. no. 45483 Validity 01. 03. 2022 – 28. 02. 2025
Issue 01. 03. 2022
A.Grisard, President SQS F.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Medical Devices Application Bulletin_CN _2_.pdf
Mevopur Healthcare Functional Additives Medical Devices Application Bulletin_CN12.15-2
https://www.avient.com/sites/default/files/2025-05/Cesa Low Retention Product Bulletin.pdf
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
KEY CHARACTERISTICS
• Eliminates secondary coating operations
• Easily delivers the last drop out of a container
• Reduces residual content
• Reduces production costs
• Won’t impact visual clarity
• Non-PFAS formulations available
APPLICATIONS
Cesa Low Retention Additives are suitable for any
olefinic application that would benefit from the
ability to repel water or fluids, including:
• Labware, including pipette tips
• Monofilaments
• Industrial fixtures
• Woven fibers
• Platform mats
• Molded optical lenses
• Medical devices
• Extruded films
• Carpet fibers
• Textiles
PRODUCT BULLETIN
https://www.avient.com/sites/default/files/2024-03/QF-02 QMS Global Standard Response.PDF
Avient can provide its
NDA form upon request
Avient Colorants Sweden AB in Malmoe and Avient Colorants USA LLC in Lewiston, Maine are Medical
Centers of Competence with an external ISO 13485 certification.
Records are established and maintained for each batch
of medical products that provides traceability and
identifies the amount manufactured and amount
approved for distribution.
https://www.avient.com/products/long-fiber-technology/benefits-long-fiber-reinforced-thermoplastic-composites
Adding fiber reinforcement to ductile thermoplastic polymers provides a substantial boost in modulus.
Longer fiber length and its intertwinement also provides resistance to crack propagation.
Inclusion of additional additives into long fiber composites can render molded articles radiopaque for medical diagnostic procedures.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Performance%2520Products%2520and%2520Solutions.pdf
HealthCare
Transportation
8%
Textiles
Target
Page 85
• Trend toward more
affordable housing
favors our product
1.5
2.0
2.5
Housing Starts
(in million units)
50 year average
Market Dynamics
• Ultimate housing
recovery presents
substantial upside to
already record-
setting results
Source: Historical Data from the US Census Bureau,
2012 estimate is a PolyOne projection.
0.0
0.5
1.0
'87 '89 '91 '94 '96 '98 '00 '02 '04 '06 '08 '10 '12
Page 86
Value Proposition
• Premier provider of specialized vinyl and supply chain solutions, leading
the industry in innovation and service
Transformation Highlights
• Management upgrades ensure that each PP&S business
Value Proposition and Transformation Highlights
• Management upgrades ensure that each PP&S business
maximizes performance
• Asset realignment and Lean Six Sigma reduce costs
• Strengthened relationship with winning customers
• Increased differentiation in all business units
> $12B Addressable Market
Page 87
Key Differentiators
• Providing application design, material design
and / or process design assistance not available
from competitors
• Capability to improve joint value streams
• We are the best innovator in our space • We are the best innovator in our space
• Expanding customers’ opportunities
by providing innovative materials
and marketing ideas
• We provide world-class customer
service and delivery performance
Page 88
13.7% 14.3%
15.5%
9.9%
6.2%
5.4%
WC % of Sales
• Best-in-class working
capital management and
delivery performance
• Improved raw material
Areas of Focus – Operational Excellence
89.1%
92.0%
94.2%
93.4% 93.4% 94.0%
On-Time Delivery
• Improved raw material
positions, sourcing savings
• PolyOne pilot site for many
LSS and manufacturing
excellence programs
*As measured to customer request date
*
Page 89
• reFlexTM Bioplasticizers
Applications: Wide variety of flexible vinyl-based products
• GeonTM HC for Healthcare
� Applications: Medical device housings, specialty tubing
� Customer benefits: Withstand aggressive antiseptics
Key Innovations
� Applications: Wide variety of flexible vinyl-based products
� Customer benefits: Lower carbon footprint,
improved productivity
• GeonTM SF Super Flow
� Applications: Large appliance parts, molded siding panels
� Customer benefits: Flame retardancy, detergent resistance
Page 90
Critical Imperatives and 2015 Goal
Critical Imperatives
• Accelerate innovation - grow in new applications not
historically served with vinyl
• Drive continuous improvement in manufacturing and
working capital efficienciesworking capital efficiencies
• Selectively leverage construction recovery
2015 Goal
• 9 - 12% return on sales
Page 91
Page 92
https://www.avient.com/sites/default/files/2020-12/packaging-solution-bulletin-selector-guide.pdf
CHEMICAL RESISTANT TPEs ADD FUNCTIONALITY THAT BRINGS VALUE
TO CONSUMERS
• Chemical Resistance – Resists aggressive
soaps, detergents, lotions, oils and solvents
found in cosmetic, personal care and
household products
• Regulatory* – Compositionally compliant
with certain FDA and REACH regulations
• Value – Economical alternative to silicone
and over-engineered medical grade TPEs
• Easy to Process – Can be injection molded
and overmolded right onto the substrate
including PP, ABS, etc
Our FDA and REACH compliant Versaflex™ PKG TPEs provide options for designing aesthetically pleasing
packaging components that withstand aggressive chemicals
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1% 1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/sites/default/files/2022-09/54139-Certificate-29AUG2022%5B98%5D.pdf
COMPOUND, SUPPLY AND PROTOTYPING SERVICES OF THERMOPLASTICS FOR THE MEDICAL DEVICE
INDUSTRY
Certificate Of Conformance